|
LRCH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.412390E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.268300E-02 |
| Normal-vs-Stage2 |
3.280000E-01 |
| Normal-vs-Stage3 |
3.445800E-01 |
| Normal-vs-Stage4 |
4.403500E-02 |
| Stage1-vs-Stage2 |
9.494600E-01 |
| Stage1-vs-Stage3 |
8.329400E-01 |
| Stage1-vs-Stage4 |
2.499000E-01 |
| Stage2-vs-Stage3 |
9.095000E-01 |
| Stage2-vs-Stage4 |
2.297400E-01 |
| Stage3-vs-Stage4 |
1.850400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.921600E-02 |
| Normal-vs-AfricanAmerican |
1.946560E-01 |
| Normal-vs-Asian |
6.439800E-02 |
| Caucasian-vs-AfricanAmerican |
9.552000E-01 |
| Caucasian-vs-Asian |
6.120800E-01 |
| AfricanAmerican-vs-Asian |
5.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.397100E-03 |
| Normal-vs-Female |
1.332040E-01 |
| Male-vs-Female |
9.411800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.754300E-02 |
| Normal-vs-Extreme_Weight |
5.918900E-03 |
| Normal-vs-Obese |
4.738000E-01 |
| Normal-vs-Extreme_Obese |
3.856000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.797800E-01 |
| Normal_Weight-vs-Obese |
2.573600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.309200E-01 |
| Extreme_Weight-vs-Obese |
8.509800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.893600E-01 |
| Obese-vs-Extreme_Obese |
5.339600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.797800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.328200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.699700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.056000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.731200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.506000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.102000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.280100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.620480E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.074800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.357610E-01 |
| Normal-VS-Type2 PRCC |
1.707610E-02 |
| Normal-VS-KIRP CIMP |
9.343800E-01 |
| Normal-VS-Unclassified PRCC |
4.289000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.376400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.364400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.461160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.056800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.512200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.059200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20859999999967E-05 |
| Normal-vs-N1 |
8.370000E-01 |
| Normal-vs-N2 |
5.227400E-01 |
| N0-vs-N1 |
2.843700E-02 |
| N0-vs-N2 |
6.822000E-01 |
| N1-vs-N2 |
5.137600E-01 |
|
|
